Management strategies of marginal ulcers

H. C. Chung, S. S. Lo, C. W. Wu, Mao-Chih Hsieh, W. Y. Lui

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Marginal ulcer is caused by inadequate initial peptic ulcer surgical procedure. Since H2 receptor antagonists have become popular as a standard treatment for peptic ulcer in the past two decades, a retrospective analysis was done to evaluate whether the H2 receptor antagonists can also be used to treat marginal ulcer. Forty-five patients with pathologically proved marginal ulcer were collected from our hospital in records over the past 10 years. Medical treatment with H2 receptor antagonists was the primary treatment for those 45 patients. Only 7 marginal ulcers healed and without recurrence. Twenty-five ulcers healed but with repeated recurrence. Surgery was suggested to another ten repeated complicated recurrent ulcers and three persistent marginal ulceration. Three patients with persistent marginal ulcer underwent elective surgery and all of these recovered without recurrence. Six patients with recurrent bleeding ulcer underwent emergency operation, and all of them were died of surgical complications, except one patient who recovered without recurrence. Although H2 receptor antagonists have a high success rate to heal marginal ulcers, however, they also have a high recurrence rate. Surgical treatment should be strongly suggested for patients with repeated recurrent bleeding ulcer.

Original languageEnglish
Pages (from-to)103-108
Number of pages6
JournalJournal of Surgical Association Republic of China
Volume31
Issue number2
Publication statusPublished - Jan 1 1998
Externally publishedYes

Fingerprint

Peptic Ulcer
Histamine H2 Receptors
Ulcer
Recurrence
Hemorrhage
Hospital Records
Therapeutics
Emergencies

Keywords

  • Marginal ulcer

ASJC Scopus subject areas

  • Surgery

Cite this

Chung, H. C., Lo, S. S., Wu, C. W., Hsieh, M-C., & Lui, W. Y. (1998). Management strategies of marginal ulcers. Journal of Surgical Association Republic of China, 31(2), 103-108.

Management strategies of marginal ulcers. / Chung, H. C.; Lo, S. S.; Wu, C. W.; Hsieh, Mao-Chih; Lui, W. Y.

In: Journal of Surgical Association Republic of China, Vol. 31, No. 2, 01.01.1998, p. 103-108.

Research output: Contribution to journalArticle

Chung, HC, Lo, SS, Wu, CW, Hsieh, M-C & Lui, WY 1998, 'Management strategies of marginal ulcers', Journal of Surgical Association Republic of China, vol. 31, no. 2, pp. 103-108.
Chung, H. C. ; Lo, S. S. ; Wu, C. W. ; Hsieh, Mao-Chih ; Lui, W. Y. / Management strategies of marginal ulcers. In: Journal of Surgical Association Republic of China. 1998 ; Vol. 31, No. 2. pp. 103-108.
@article{e9ccbd1c8f784cffa3c4d97e222a0b1c,
title = "Management strategies of marginal ulcers",
abstract = "Marginal ulcer is caused by inadequate initial peptic ulcer surgical procedure. Since H2 receptor antagonists have become popular as a standard treatment for peptic ulcer in the past two decades, a retrospective analysis was done to evaluate whether the H2 receptor antagonists can also be used to treat marginal ulcer. Forty-five patients with pathologically proved marginal ulcer were collected from our hospital in records over the past 10 years. Medical treatment with H2 receptor antagonists was the primary treatment for those 45 patients. Only 7 marginal ulcers healed and without recurrence. Twenty-five ulcers healed but with repeated recurrence. Surgery was suggested to another ten repeated complicated recurrent ulcers and three persistent marginal ulceration. Three patients with persistent marginal ulcer underwent elective surgery and all of these recovered without recurrence. Six patients with recurrent bleeding ulcer underwent emergency operation, and all of them were died of surgical complications, except one patient who recovered without recurrence. Although H2 receptor antagonists have a high success rate to heal marginal ulcers, however, they also have a high recurrence rate. Surgical treatment should be strongly suggested for patients with repeated recurrent bleeding ulcer.",
keywords = "Marginal ulcer",
author = "Chung, {H. C.} and Lo, {S. S.} and Wu, {C. W.} and Mao-Chih Hsieh and Lui, {W. Y.}",
year = "1998",
month = "1",
day = "1",
language = "English",
volume = "31",
pages = "103--108",
journal = "Formosan Journal of Surgery",
issn = "1011-6788",
publisher = "臺灣外科醫學會",
number = "2",

}

TY - JOUR

T1 - Management strategies of marginal ulcers

AU - Chung, H. C.

AU - Lo, S. S.

AU - Wu, C. W.

AU - Hsieh, Mao-Chih

AU - Lui, W. Y.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Marginal ulcer is caused by inadequate initial peptic ulcer surgical procedure. Since H2 receptor antagonists have become popular as a standard treatment for peptic ulcer in the past two decades, a retrospective analysis was done to evaluate whether the H2 receptor antagonists can also be used to treat marginal ulcer. Forty-five patients with pathologically proved marginal ulcer were collected from our hospital in records over the past 10 years. Medical treatment with H2 receptor antagonists was the primary treatment for those 45 patients. Only 7 marginal ulcers healed and without recurrence. Twenty-five ulcers healed but with repeated recurrence. Surgery was suggested to another ten repeated complicated recurrent ulcers and three persistent marginal ulceration. Three patients with persistent marginal ulcer underwent elective surgery and all of these recovered without recurrence. Six patients with recurrent bleeding ulcer underwent emergency operation, and all of them were died of surgical complications, except one patient who recovered without recurrence. Although H2 receptor antagonists have a high success rate to heal marginal ulcers, however, they also have a high recurrence rate. Surgical treatment should be strongly suggested for patients with repeated recurrent bleeding ulcer.

AB - Marginal ulcer is caused by inadequate initial peptic ulcer surgical procedure. Since H2 receptor antagonists have become popular as a standard treatment for peptic ulcer in the past two decades, a retrospective analysis was done to evaluate whether the H2 receptor antagonists can also be used to treat marginal ulcer. Forty-five patients with pathologically proved marginal ulcer were collected from our hospital in records over the past 10 years. Medical treatment with H2 receptor antagonists was the primary treatment for those 45 patients. Only 7 marginal ulcers healed and without recurrence. Twenty-five ulcers healed but with repeated recurrence. Surgery was suggested to another ten repeated complicated recurrent ulcers and three persistent marginal ulceration. Three patients with persistent marginal ulcer underwent elective surgery and all of these recovered without recurrence. Six patients with recurrent bleeding ulcer underwent emergency operation, and all of them were died of surgical complications, except one patient who recovered without recurrence. Although H2 receptor antagonists have a high success rate to heal marginal ulcers, however, they also have a high recurrence rate. Surgical treatment should be strongly suggested for patients with repeated recurrent bleeding ulcer.

KW - Marginal ulcer

UR - http://www.scopus.com/inward/record.url?scp=0031754356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031754356&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031754356

VL - 31

SP - 103

EP - 108

JO - Formosan Journal of Surgery

JF - Formosan Journal of Surgery

SN - 1011-6788

IS - 2

ER -